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Abstract
Aims: Alcohol septal ablation (ASA) is an established treatment option in hypertrophic obstructive car-
diomyopathy (HOCM). ASA is ineffective in some: inaccurate infarct and inability to identify a vessel 
contribute. We aimed to improve accuracy of infarct using CT angiography guidance and provide a more 
predictable and satisfactory outcome.
Methods and results: Twenty-one successive patients with symptomatic LVOT obstruction refractory to 
medication underwent CT angiography planning to guide ASA. CT was performed using a dual-source CT 
system. Alcohol was delivered to the artery identified from CT: in 17/21 this was a sub-branch of a sep-
tal artery, in 2/21 the septal vessel was identified from the circumflex artery. Peak gradient improved from 
98 (IQR 89.50-111.50) mmHg to 14 (IQR 8.50-22) mmHg (p=0.003). Systolic anterior motion (SAM) 
improved in 18/20 patients. NYHA class improved by ≥1 in 18/20. Peak VO2 improved from 79.19% of 
predicted value (±14.01) to 91.62% (±12.02) predicted (p<0.0001). Success at the first procedure is greater 
with CT guidance, 17/20 vs. 50/75 with traditional methods (pre-CT guidance) (p=0.02); 9/20 had six-
month CMR with target septum infarct in all. ASA-related RBBB reduced from 62% to 13% (p=0.0004).
Conclusions: CT angiography planning improves localisation of infarct and procedural success at the first 
attempt in ASA when compared to traditional methods. Follow-up to six months suggests a symptomatic, 
functional and haemodynamic improvement.
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Abbreviations
ASA alcohol septal ablation
CT computed tomography
HOCM hypertrophic obstructive cardiomyopathy
LAD left anterior descending
LV left ventricle
MV mitral valve
NYHA New York Heart Association
RCA right coronary artery
RV right ventricle
SAM systolic anterior motion
Introduction
Hypertrophic cardiomyopathy (HCM) is an inherited disease 
characterised by otherwise unexplained hypertrophy of the myo-
cardium. Whilst the distribution of hypertrophy can be variable, 
involvement of the basal interventricular septum is common. 
This anatomical pattern is associated with the development of left 
ventricular outflow tract (LVOT) obstruction, present in 20-30% 
of subjects at rest and in 70% on exercise or with provocation1. 
Systolic anterior motion (SAM) of the mitral valve is critical to 
the pathophysiology of LVOT gradient development in hyper-
trophic obstructive cardiomyopathy (HOCM). SAM-septal contact 
leads to an amplifying positive-feedback loop which further nar-
rows the LVOT. This results in increasing LVOT flow velocities 
and gradients2. LVOT obstruction is associated with greater levels 
of dyspnoea, a greater incidence of stroke and higher mortality1. 
Treatment with alcohol septal ablation (ASA) can improve symp-
toms and has been suggested to improve prognosis3.
ASA causes death of myocardial tissue akin to a myocardial 
infarction. The reduction in size and systolic excursion of the 
septum leads to an increased LVOT area. The target for the iat-
rogenic infarct is the site of contact of the anterior mitral valve 
leaflet on the septum (SAM-septal contact). This reduces SAM 
and therefore gradients. Failure to resolve the LVOT gradient 
is seen in a substantial proportion of patients4,5. This can occur 
with inaccurate infarct location. Better localisation of iatrogenic 
infarct could lead to a more predictable and satisfactory outcome 
from ASA.
Current procedural methods rely on identifying a target ves-
sel from invasive angiography and investigating with myocardial 
contrast echocardiography6. Invasive angiography provides infor-
mation about the course and size of coronary arteries, but can-
not provide information about the territories supplied. Computed 
tomography (CT) angiography has the dual benefit of detailing 
vascular anatomy and providing information on myocardial distri-
bution. CT has been used in an exploratory manner to assist in ASA 
previously7. We describe a new method using CT angiography to 
describe septal vascular supply in preparation for ASA. This high-
lights the specific optimum target vessel (usually a branch division 
of the septal system) for alcohol delivery. We also describe out-
comes in a consecutive series of patients undergoing ASA guided 
by CT, and compare this group to historic controls.
Methods
PATIENT SELECTION
Twenty-one consecutive patients who received alcohol to the tar-
get septal artery are described. A patient consort diagram is pro-
vided in Figure 1. A diagnosis of HCM was made according to 
typical clinical, electrocardiographic and echocardiographic fea-
tures. All patients taken to the laboratory had resting, Valsalva 
manoeuvre or exercise stress peak LVOT gradient ≥50 mmHg and 
basal interventricular septal diameter ≥15 mm. All were trialled 
on medications prior to ASA. The mean age was 57.41 (±14.84) 
years, and 62% were male. One patient had significant lung dis-
ease, two had previous PCI. Three patients had undergone ASA 
previously with unsatisfactory outcome.
Appropriate permissions to perform CT prior to clinically indi-
cated ASA were provided by the research and development board 
of Liverpool Heart and Chest Hospital.
ECHOCARDIOGRAPHIC ASSESSMENT
A resting echocardiogram was performed >24 hours prior to ASA 
(Philips iE33 scanner, Philips S5-1 probe; Philips Healthcare, 
Best, The Netherlands). SAM severity grading was adapted to pro-
vide a binary option of “contact with septum” or “no contact with 
septum” to allow statistical analysis. This is based on the observa-
tion that the majority of the increased flow velocity in the LVOT 
is related to SAM-septal contact2.
CARDIOPULMONARY EXERCISE (CPEX) TESTING
CPEX was performed using a bicycle ergometer with 10 W 
minutely increments in workload. Patients were exercised until 
a respiratory exchange ratio (RER) of >1.1 was reached; mean 
readings of the last 30 seconds of exercise were used.
CT IMAGE ACQUISITION
Coronary computed tomography angiography (CTA) was per-
formed using a dual-source CT system (SOMATOM Definition 
Total patients assessed  49
Medical management 20
Surgical management 3
Entered lab for ASA 26
Received alcohol 21
Unable to access target septal 2
Contrast vented directly to LV 2
Surgical management 1
Figure 1. Patient consort diagram: all patients referred for ASA.
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Flash; Siemens Healthcare, Forchheim, Germany). All patients 
with a heart rate greater than 60 beats per minute were given either 
oral or intravenous metoprolol. Axial data acquisition was pro-
spectively triggered at 70% of the RR interval. A lower 25% dose 
was given during 30 to 80% of the cardiac cycle to obtain systolic 
frames and SAM-septal contact area.
To synchronise acquisition of the data set to arterial enhance-
ment, a test bolus protocol was used; 15 mL contrast agent 
(Optiray™ 350; Covidien/Medtronic, Dublin, Ireland) was fol-
lowed by 40 mL saline solution at 6 mL/s. The time to peak 
enhancement in the aorta was measured using a series of transax-
ial scans acquired in 2 s increments, with the first image acquired 
after 12 s. For CTA, 60 mL of contrast was injected followed by 
a mixed flush (10 mL contrast and 30 mL saline), both at flow 
rates of 6 mL/s. For image reconstruction, a half scan reconstruc-
tion algorithm was used, providing a temporal resolution of 75 ms. 
The reconstructed slice thickness was 0.6 mm, and the slice incre-
ment was 0.3 mm.
CT IMAGE ANALYSIS
The reconstructed images were analysed with syngo.via (Siemens 
Healthcare). The target area of myocardium was identified using 
a short section of systolic imaging (Figure 2). This target myo-
cardium at the SAM-septal contact area was examined in diastole 
to identify a segment of its arterial branch supply (Figure 2, 
Figure 3). This vessel was tracked back to its parent artery. Other 
characteristics of the septal vessel including the angle of bifur-
cation from its parent artery, the length of its course in epicar-
dial fat (before septal penetration) and myocardium, its branch 
pattern, and the ultimate myocardial territories of all branches 
were noted (Figure 3). The target artery was traced and marked 
and a coronary angiogram “map” created. The coronary map 
was then rotated through horizontal and vertical planes to allow 
optimal visualisation and remove any overlap or foreshortening 
(Moving image 1). The optimum angiographic projections were 
then used as the “working views” in the catheterisation laboratory 
(Figure 4). Finally, the left main stem, LAD, circumflex and RCA 
were surveyed for other vessels tracking towards the septum. All 
potential target vessels were followed and the ultimate distribution 
noted. This was to allow identification or rejection as an additional 
target vessel.
ALCOHOL SEPTAL ABLATION PROCEDURE
Patients without a permanent pacing system had a temporary 
pacing wire (TPW) placed in the RV apex. NBIH™ bipolar pac-
ing wires (6 Fr) (Bard Medical, Covington, GA, USA) were used 
for the first 14 patients; 5 Fr Bard balloon flow-assisted bipolar 
wires were used after that. The working projections identified 
Figure 2. Septal artery tracking in 2D CT. A) Three-chamber systolic CT image displaying SAM of the MV. The contact area is seen in the 
basal septum. B) The target area of myocardium in the basal septum is located at the centre of the coloured lines – a short-axis view is 
displayed in Panel C. The centre point of these lines is the same target myocardium in each image. This myocardium is then surveyed for 
evidence of a coronary artery; the vessel is traced back to its parent epicardial vessel and examined (D).
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from CT to visualise the origin of the target septal from its parent 
vessel were implemented. A coronary wire was passed into the 
target septal. A traditional approach to contrast echo studies was 
employed first. An over-the-wire (OTW) balloon was inflated in 
the common ostium of the target septal with subsequent contrast 
injection and echocardiographic studies. OTW balloons were 
intentionally short; typical balloon sizes were 1.5×8 mm and 
2.0×8 mm. If contrast was seen to travel to the RV septum or RV 
cavity (as predicted by CT), alcohol was not injected (Figure 5, 
Moving image 2). This was often in addition to some opacifica-
tion of the LV septum. The wire was then passed in to the tar-
get sub-branch of the septal vessel. A second set of views was 
identified from CT to visualise the distal branch pattern. Once 
the wire was in the proximal portion of the vessel, the angio-
graphic projections were changed to allow navigation into the 
chosen sub-branch as advised by CT (Moving image 1). When 
the wire was secure in the desired sub-branch, the OTW balloon 
was advanced and inflated to allow delivery of contrast and alco-
hol. If the target myocardium was not completely covered during 
Figure 3. Anatomical details taken from 2D CT images. A) Short-axis 
view at the level of target myocardium. A septal artery was seen and 
highlighted (B). C) Septal vessel with a measurement of the distance 
travelled from parent vessel to entry into the myocardium. D) Total 
length of septal vessel from ostium. E) Angle of entry from LAD into 
septal. F) Area of septal vessel.
Figure 4. CT angiography with matched invasive angiography 
projections. A) CT angiogram. The traced septal vessels from 2D 
images were projected onto the coronary angiogram “map” (Moving 
image 1). This CT angiogram was rotated to minimise foreshortening 
and remove overlap (in this example to RAO cranial). The equivalent 
invasive angiogram projection is shown in panel B. The target artery 
is identified and only this sub-branch is occluded for alcohol 
delivery. Further examples are shown in panels C & D and E & F.
myocardial contrast echo studies, additional target vessels were 
explored (n=1). The delivery of alcohol was guided by CT and 
confirmed by myocardial contrast studies in all patients. Other 
aspects of the procedure were as described previously6.
STATISTICAL ANALYSIS
Continuous data are presented as means and SD, or medians and 
IQR for data that are non-parametric. Paired t-tests were used for 
parametric data and Wilcoxon signed-rank tests for non-paramet-
ric data. Change in the categorical extent of SAM2 was assessed 
using the sign test. Statistical analysis was performed using 
StatsDirect, version 2.8.0 (StatsDirect Ltd, Altrincham, Cheshire, 
United Kingdom).
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COMPARISON TO TRADITIONAL ASA
We have reported our outcomes in 88 patients managed with con-
ventional ASA5. Our experience mirrors international norms4,8,9. 
We compared the results of the CT-guided cohort against our his-
toric controls.
Fisher’s exact test was used to compare success in treating 
LVOT gradients after one procedure; failure was defined as a per-
sisting gradient of >50 mmHg or failure to reduce the gradient by 
greater than 50%. Fisher’s exact test was also used to compare 
Figure 5. Myocardial contrast echocardiography studies. 
A) Parasternal long-axis echo view with relevant structures 
highlighted. Contrast injection into the common ostium of a septal; 
myocardial contrast is seen predominantly in the RV (B). There is 
some hyperenhancement in the target septum but this passes quickly 
(Moving image 2). C) Contrast localises to the target myocardium 
following occlusion of the chosen sub-branch.
the incidence of procedure-related complications. We compared 
the relationship between alcohol dose and myocardial damage as 
a reflection of the control of the procedure using Pearson’s correla-
tion coefficient between alcohol dose injected and CKMB release.
Results
PROCEDURAL DETAILS
All procedures were performed by R. Stables. Twenty-one patients 
received alcohol to the target septal artery. One patient under-
went a second ASA procedure in the study period. Alcohol was 
injected into two septal arteries at the same procedure in one fur-
ther patient. Mean volume of alcohol delivered was 1.95 (±0.62) 
mL. Mean CKMB release was 116.65 (±63.30) ng/dL (reference 
range <5 ng/dL). A correlation between alcohol dose and CKMB 
release was seen; the R value was 0.46 (p=0.03) (Figure 6).
SEPTAL ARTERIAL ANATOMY IDENTIFIED BY CT
CT analysis revealed a total of 49 vessels travelling to the basal 
septum, an average of 2.33±1.55 septals per patient (range 1-6). 
Of these vessels, 24 were deemed to be to target myocardium at 
the SAM-septal contact point (one vessel per patient in 18, two 
vessels per patient in three). Eighteen of the 24 (75%) had LV and 
RV supply. Seven of the 24 (29%) had a third territory supplied 
also (anterior wall n=3, inferior wall n=2, LV mid septum n=2).
ADAPTATION TO TRADITIONAL METHODS BASED ON 
INFORMATION FROM CT
The information from CT altered the approach to ASA. For 
17 patients, CT angiography highlighted the target for alcohol to 
be a specific sub-branch of a septal vessel. A sub-selective alco-
hol injection into the specific target branch was advised in these 
patients. In those septals with a branch to the RV (n=17), the ini-
tial contrast injection into the ostium of the vessel resulted in some 
opacification of the RV septum or cavity in all. Manipulation of 
the wire into the chosen sub-branch improved contrast localisation 
to the LV septum. In two procedures, the parent epicardial vessel 
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Figure 6. Relationship of alcohol dose and infarct size as assessed by 
CKMB release. In our historic controls treated with traditional 
methods there is a weak relationship; R value of 0.14 (p=0.15). In 
the CT-guided cohort, the relationship is much stronger; R value of 
0.46 (p=0.03).
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for the target septal branch was the circumflex artery. For a fur-
ther two procedures a small septal artery was identified from the 
proximal LAD.
PROCEDURAL COMPLICATIONS
Complete heart block requiring permanent pacemaker implanta-
tion was seen in 2/21 patients. Two patients developed minor peri-
cardial effusion (<10 mm) without tamponade; no treatment was 
required. No late gadolinium enhancement was seen outside the 
target basal septum at three-day or six-month CMR scans. This 
was presumed to be due to perforation of the right ventricular wall 
by a TPW. No effusion was seen at repeat echocardiography at one 
month. New RBBB was seen in 2/16 (three paced prior to ASA to 
treat LVOT gradients, two with complete heart block [CHB] and 
permanent pacemaker [PPM] as a result of ASA), and new LBBB 
was seen in 1/16.
SURVIVAL AND RISK OF VENTRICULAR ARRHYTHMIA
Follow-up data are presented for a mean period of 375 (±137) 
days. All patients had assessment >180 days from ASA. One 
patient would not return for clinical assessment but reported 
improved symptoms by telephone consultation. No patient who 
received alcohol to the target artery died or suffered ventricular 
arrhythmia.
SYMPTOMATIC RESOLUTION
Symptoms of dyspnoea improved in 18 (90%), and mean NYHA 
class improved from 2.85 (±0.11) to 1.45 (±0.39) (p<0.0001) 
(Table 1). Ten patients improved from Class III to Class I. Five 
patients improved from Class III to Class II. Three patients 
improved from Class II to Class I and experienced resolution 
of recurrent pre-syncope. Two patients found no benefit and 
remained in Class III (one developed pulmonary fibrosis and 
had persistent dyspnoea despite successful gradient resolution). 
Chest pain was reported in 11/20 prior to ASA, all resolved with 
ASA (p=0.005).
ECHOCARDIOGRAPHIC DATA
Twelve of 20 patients had a resting gradient of ≥50 mmHg, and 
a further eight had a resting gradient of <50 mmHg and a Valsalva 
or exercise stress-induced gradient of ≥50 mmHg. Those with 
a resting gradient ≥50 mmHg improved from 98 (IQR 89.50-
111.50) mmHg to 14 (IQR 8.50-22) mmHg (p=0.003). Two of 12 
had a persisting gradient of ≥50 mmHg at the end of the study 
period. These patients had failure of resolution of LVOT gradient 
according to the predefined criteria detailed in the Methods section. 
In those with a provoked gradient, we saw an improvement from 
82 (IQR 73.25-108.75) mmHg to 22 (IQR 16.25-31.50) mmHg 
(p=0.007). None had a provoked gradient ≥50 mmHg after ASA.
SAM improved in 18/20 patients (p=0.0008). Eighteen of 
20 patients had SAM-septal contact at rest prior to ASA; 2/20 
had contact after treatment. Two patients had SAM-septal contact 
associated with high LVOT gradients on exercise; neither had con-
tact on exercise after ASA. Those with persisting SAM-septal con-
tact had significant LVOT gradients.
Interventricular septal thickness in diastole decreased from 21 (IQR 
20-23.25) mm to 17 (IQR 15-18.50) mm (p<0.0001). Left atrial diam-
eter decreased from 48 (±7.07) mm to 42.10 (±7.14) mm (p=0.0002).
CARDIOPULMONARY EXERCISE TEST
Satisfactory CPEX data were available in 17 patients. Peak 
VO2 increased from 19.09 (±6.34) to 21.45 (±6.59) mL/min/
kg (p<0.0001), representing an increase from 79.19% of pre-
dicted value (±14.01) to 91.62% predicted (±12.02) (p<0.0001). 
Exercise time improved from 715.59 (±252.35) seconds to 837.35 
(±265.10) seconds (p<0.0001).
QUALITY OF LIFE
EQ5D-5L questionnaires were completed before and >6 months 
after ASA in 15 patients. The index value improved in all, with an 
increase from 0.51 (±0.24) to 0.78 (±0.16) (p<0.0001). The over-
all health score increased in 14/15 patients, values improving from 
49.00 (±16.32) to 71.67 (±16.00) (p=0.0012).
Table 1. Measured values pre and post CT-guided ASA.
Parameter Pre-ASA SD/IQR Post-ASA SD/IQR p-value
NYHA class 2.85 0.11 1.45 0.39 <0.0001
LVOT gradient (mmHg) 98 89.50-111.50 14 8.50-22.0 0.003
Provoked LVOT gradient in those with 
resting gradient <50 mmHg 82 73.25-108.75 22.50 16.25-31.5 0.007
Presence of severe SAM 18/20 – 2/20 – 0.0008
Septal thickness in diastole (mm) 21 20.0-23.25 17 15.0-18.50 <0.0001
Left atrial diameter (mm) 48 7.07 42.10 7.14 0.0002
Peak VO2 (mL/min/kg) 19.09 6.34 21.45 6.59 <0.0001
% Predicted VO2 79.19 14.01 91.62 12.02 <0.0001
Exercise time (sec) 715.59 252.35 837.35 265.10 <0.0001
EQ5D-5L index value (0-1) 0.51 0.24 0.78 0.16 <0.0001
EQ5D-5L health score (0-100) 49.00 16.32 71.67 16.0 0.0012
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COMPARISON TO TRADITIONAL ASA
Successful LVOT gradient resolution after receiving alcohol as 
part of a single ablation procedure was observed in 17/20 (85%) 
cases in CT-guided ASA and 44/75 (59%) in the traditional 
methods groups (p=0.02). Those who did not receive alcohol 
were excluded from both the traditional methods group and the 
CT-guided study group.
To ensure the improvement was related to CT methods and 
not to the well-recognised learning curve associated with ASA, 
we analysed the last 20 patients treated with traditional methods. 
This group represented procedure numbers 105-124 performed at 
our centre at a rate of 10/year. This is in keeping with interna-
tional guidance for adequate training10. This group had the same 
success at first procedure rate, i.e., 12/20 (60%) compared to 
44/75 (59%) (p=0.92). When comparing the CT-guided group to 
the most recent traditional method group, we see a trend towards 
improvement with CT, i.e., 17/20 (85%) vs. 12/20 (60%) (p=0.09). 
Statistical significance is lost due to smaller numbers in the sub-
selected traditional group.
New RBBB was observed in 2/16 (13%) patients treated with 
CT-guided ASA and 42/68 (62%) patients treated with traditional 
methods (p=0.0004) (Table 2). CHB requiring pacemaker implan-
tation was seen in 2/21 (10%) in the CT-guided group and 14/74 
(17%) in the traditional ASA group (p=0.17).
The total alcohol dose delivered was not significantly different 
between groups (2.24±1.08 in traditional ASA vs. 1.95±0.62 mL 
in CT-guided ASA [p=0.20]). Alcohol dose to CKMB release had 
a significant correlation in the CT-guided group (R value 0.46, 
p=0.03), whereas no significant correlation was seen in the tradi-
tional group (R value 0.15, p=0.14) (Figure 6).
Symptom improvement, defined by change in NYHA class, 
was seen in 18/20 (90%) patients with CT-guided ASA and 55/75 
(73%) patients treated with traditional methods (p=0.12). Direct 
comparisons are difficult as patients in the traditional group 
received a greater number of doses of alcohol, 1.23 (±0.48) vs. 
1.05 (±0.22) in the CT-guided group (p=0.17).
PATIENTS UNABLE TO RECEIVE ALCOHOL AND 
INTENTION-TO-TREAT
Five patients did not receive alcohol (Figure 1). In two patients 
we could not safely access the septal artery predicted to supply the 
target area by CT. The coronary wire had to negotiate many turns, 
and when the OTW balloon was advanced the wire prolapsed back 
into the parent epicardial artery. These patients were forwarded 
for an alternative form of septal reduction therapy (radiofrequency 
ablation in three, myectomy in one). One patient died three months 
later following a stroke whilst awaiting a further treatment deci-
sion. These patients are not included in the outcome analysis as 
they did not have repeat assessment including echocardiography 
and CPEX prior to further treatment.
Four of five patients were included in an intention-to-treat analy-
sis (myectomy patient excluded). This used the pre-assessment 
echocardiographic data as the post-assessment value as no treat-
ment was delivered (no repeat data were available prior to com-
pleting the next treatment modality for LVOT obstruction). Using 
this method, the resting LVOT gradient improved from 64 (IQR 
28-100), provoked gradient 96 (IQR 78-120) to 23 (IQR 9-30), 
provoked 62 (IQR 14-39), respectively (p<0.0001). The success 
rate following one procedure was then 71% (17/24). Comparison 
to a traditional group is difficult as the indications to enter the lab 
for ASA have evolved. Including all patients who entered the lab 
for ASA, the success rate of the traditional group after first proce-
dure was 51% (44/86) (p=0.09). This type of analysis holds many 
unavoidable limitations.
Discussion
CT angiography can provide high-quality images of septal coro-
nary arteries. The images provide anatomic insights that have 
altered our approach to alcohol delivery in ASA.
A septal artery can often be seen on CT to supply both the RV 
septum and the LV septum, which are very different environments. 
This has implications for variable “run-off”. Any fluid injected 
into the proximal portion of this artery will follow the path of 
Table 2. Comparison of procedural control and success with traditional and CT-guided ASA.
Traditional ASA CT-guided ASA p-value
Age 60.3 (±14.3) 57.41 (±14.84) n/s
Male (%) 48 62 n/s
Follow-up (years) 4.2 1.1 –
LVOT gradient success after one procedure 44/75 (59%) 17/20 (85%) 0.02
Alcohol to CKMB correlation R value 0.14 (p=0.15) 0.46 (p=0.03) –
ASA-induced RBBB 42/68 (62%) 2/16 (13%) 0.0004
PPM requirement 14/74 (17%) 2/21 (10%) 0.17
Pre Post Pre Post
LVOT gradient (provoked) 99.80 23.77 64 (96) 18 (24) 0.95
Septal diameter (mm) 22.3 17.3 21.4 17.1 0.95
Left atrium diameter (mm) 45.9 44.6 48.0 42.1 0.02
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least resistance. This means that contrast (or alcohol) will flow 
into the low-pressure circuit of the RV septum and drain directly 
into the RV cavity via Thebesian veins, rather than enter the high-
pressure circuit of the densely packed hypertrophied LV septum. 
Traditional teaching for alcohol ablation is to site a coronary bal-
loon at the ostium of the septal artery, and inject beyond11,12. This 
would result in echocardiographic contrast highlighting the RV; 
this pattern of myocardial contrast has been described as the most 
common undesirable location. The vessel would then be dismissed 
as serving an incorrect area of myocardium. Engaging the sub-
branch of the septal vessel that supplies the LV myocardium can 
result in target myocardium being highlighted (Figure 6, Moving 
image 2). An artery that would previously have been dismissed 
now becomes an ideal target.
The variable branching pattern involving right and left ventricu-
lar myocardium also has an effect on the ability of injected alcohol 
to damage myocardium. The differing and unpredictable coronary 
pressures affect vascular resistance, the route and rate of venous 
drainage and hence the “dwell time” of alcohol in the myocar-
dium. This was reflected in the poor correlation between alco-
hol dose and CKMB release in our traditional ASA group. This is 
much improved when injecting into selective LV branches identi-
fied by CT, with a more predictable amount of damage observed.
The parent vessel for the appropriate septal artery is not always 
the LAD. Patients have been identified with basal septum supply 
from the circumflex and intermediate arteries11 and right coronary 
artery. In 5/59 patients in one series, the target vessel did not origi-
nate from the LAD. These patients may be dismissed as not hav-
ing an appropriate artery by operators who may not consider other 
parent arteries13. The approach to identifying the correct artery is 
reversed in CT. In traditional ASA, we follow a vessel from its 
origins. Using CT, we identify the appropriate vessel for alcohol 
delivery in the target myocardium and track it back to its source, 
wherever that parent artery may be. This will avoid missing ves-
sels due to unexpected origins.
Myocardial contrast echocardiography (MCE) remains a pre-
requisite in ASA; CT and MCE are to be used as complementary 
modalities. In this study, MCE was used as a proof of concept to 
display vascular supply to both the LV septum and the RV septum 
in those predicted to have dual supply, prior to engaging our true 
target sub-branch.
CT-GUIDED APPROACH IMPROVES CONTROL OF INFARCT 
SIZE AND LOCATION
CT-guided ASA may afford greater control of the size and loca-
tion of infarct. The increased control is suggested by the better 
correlation of alcohol dose to CKMB release. Previously, it was 
difficult to predict the extent of myocardial damage, in part due to 
the inability to control variable run-off into different myocardial 
territories. We can now predict the extent of myocardial damage 
as indicated by CKMB release.
RBBB was a very common procedural observation using tradi-
tional methods8,14,15. RBBB has even been suggested as a predictor 
of good outcome from ASA15. Whilst this association is seen, it 
is probably explained by the presence of transmural infarcts that 
incorporate left and right ventricular myocardium14. Infarction of 
the right bundle is collateral damage and should not be the pri-
mary target. The true target is the left ventricular myocardium, 
aiming to reduce size and systolic excursion into the LVOT. Both 
changes have an effect on LV haemodynamics. It is not simply 
reduction in the size of the septum we seek, as gradients can be 
reduced significantly with minimal change. This is observed in 
radiofrequency ablation of the septum16. The reduction in systolic 
excursion of the septum and hence SAM is responsible for this 
reduction in gradients.
The significant reduction in RBBB in CT-guided ASA is indic-
ative of more targeted infarct in the LV myocardium. This has 
been confirmed by CMR studies. Seven of nine patients who 
were able to undergo CMR post ASA showed RV endocardial 
sparing (Figure 7). We were unable to perform CMR in 11 (ICD/
PPM in nine, claustrophobia in two). CT allows us to target the 
appropriate LV myocardium with greater accuracy.
EFFECT OF BETTER INFARCT LOCALISATION ON CLINICAL 
OUTCOMES
A more accurate infarct will create a more favourable effect on 
LVOT haemodynamics. Mean gradients and symptom burden 
were much improved after CT-guided ASA. This has been true for 
most case series reported historically. The average gradient in the 
CT group is composed of a greater proportion of successful pro-
cedures than in our traditional group. This is despite there being 
a reduced need for additional procedures to reach this outcome. 
This greater procedural success rate results in an improved exer-
cise capacity and a trend towards a greater proportion of patients 
reporting a symptomatic improvement. This does not reach statis-
tical significance compared to the effect of a traditional approach 
in this relatively small group of patients.
RADIATION RISKS
The mean radiation dose per CT scan was 3.28 mSv. A proce-
dure with this dose is classed as low risk with a <1 in 10,000 
additional risk of fatal cancer in an adult17. A standard angio-
gram with 4.3 minutes screening time and seven diagnostic 
shots uses 3.9-4.9 mSv (this is the UK average)17. The mean 
radiation dose for ASA was 9.04 mSv (3.84-34.08 mSv). The 
use of CT is leading to more effective treatment at the first 
attempt (p=0.02). These adaptations will ultimately reduce the 
delivered radiation to the population and compensate for the 
small dose from CT.
Conclusions
CT angiography has changed our approach to ASA. This refined 
approach improves control and location of iatrogenic infarct. This 
is translating into greater success in treating LVOT gradients at 
the first procedure and has potential to have a greater impact on 
patients’ symptoms.
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Impact on daily practice
A substantial proportion of patients undergoing alcohol septal 
ablation for obstruction in hypertrophic cardiomyopathy have 
significant persisting LVOT gradients, often due to inaccurate 
location of the iatrogenic infarct. CT angiography planning 
with alcohol injection into pre-identified sub-branches of septal 
arteries improves localisation of infarct. This improved accu-
racy leads to a greater success in treating LVOT gradients at 
first procedure and is translating into improved symptoms and 
functional status.
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Supplementary data
Moving image 1. The process of CT identification of the septal artery 
and subsequent ASA procedure. The initial image shows the SAM-
septal contact area on the septum. This frame is in systole. The next 
image shows the same myocardium in the basal septum in dias-
tole. The three-chamber diastolic image is part of a four-panel rela-
tional CT image displayed in the syngo.via workstation. The central 
point of the cross-sectional lines is the same in each of the three 
2D images. A septal vessel is seen tracking into the target myocar-
dium in the short-axis view when the image is zoomed in (labelled 
by white arrows). This vessel is then tracked, and the line created 
when tracking this target vessel is then transferred to a 3D rota-
tional angiogram. The familiar major epicardial vessels are seen in 
the traditional shade of orange. The target septal vessel is repre-
sented by the yellow line, and other branches of the same vessel 
which travel to territories that we do not wish to infarct are repre-
sented by the green lines. This angiogram is then rotated to display 
the septal artery in a range of projections that are possible in the 
catherisation lab. The aim is to choose familiar views that remove 
foreshortening and overlap, and display the fine detail of the ves-
sel to allow the operator to navigate a wire to the target sub-branch. 
We often choose one projection to enter the mouth of the septal 
vessel, and another to expose the necessary detail to pass to the 
distal target branch. Examples of the images created by CT with 
invasive angiograms are shown in RAO cranial, plain AP and LAO 
caudal. In the last example, the LAO caudal view was used to pass 
the over-the-wire balloon to the correct sub-branch. Myocardial 
contrast was delivered after balloon occlusion, localising to the tar-
get myocardium on echocardiography. Alcohol was delivered; the 
subsequent angiogram shows no reflow in the target sub-branch. 
Echocardiography at six months shows resolution of gradient with 
good localisation of infarct in the basal septum. SAM has resolved.
Moving image 2. Myocardial contrast echocardiography with tra-
ditional balloon occlusion in the mouth of the septal vessel and 
then on selective sub-branch occlusion. On-table transthoracic 
echocardiography. The first contrast injection is seen in the paraster-
nal long-axis view. Contrast was injected into the common stem of 
the septal vessel as per traditional methods. This briefly localises to 
the basal septum and then washes out into the right ventricle. In the 
second injection, the balloon has been advanced into the target sub-
branch, selective injection localises to the target septum only and 
has a long “dwell time” in the myocardium.
The supplementary data are published online at: 
http://www.pcronline.com/
eurointervention/112th_issue/??
 
